Navigation

propylhexedrine (Benzedrex)

 

Classes: Decongestants, Intranasal

Dosing and uses of Benzedrex (propylhexedrine)

 

Adult dosage forms and strengths

intranasal inhaler

  • 250mg/actuation

 

Nasal Congestion

1-2 inhalations per nostril q2hr PRN; not to exceed 3 days

 

Pediatric dosage forms and strengths

intranasal inhaler

  • 250mg/actuation

 

Nasal Congestion

<6 years: Not recommended

≥6 years: 1-2 inhalations per nostril q2hr PRN; not to exceed 3 days

 

Benzedrex (propylhexedrine) adverse (side) effects

Systemic side effects more common in patients with heart disease, especially if overused

 

Frequency not defined

Anxiety

Restlessness

Tremor

Sweating

Stinging

Dryness

Rebound congestion

Burning

 

Warnings

Contraindications

Hypersensitivity to drug or components

Within 14 days of MAO inhibitor therapy

 

Cautions

WARNING: may be extracted & injected IV as amphetamine substitute by abusers: Potential for cardiomyopathy, dyspnea, death

Caution in cardiac disease (increase BP, HR, palpitations)

 

Pregnancy and lactation

Pregnancy category: C

Lactation: not known if excreted in breast milk

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Benzedrex (propylhexedrine)

Mechanism of action

Cycloalkylamine; alpha adrenergic agonist; stimulates alpha-adrenergic receptors in nasal conjunctiva and arterioles to produce vasoconstriction that results in nasal decongestion

 

Pharmacokinetics

Absorption: Minimal systemic

Onset: 30 sec-5 min

Duration: 30 min-2 hr

Metabolism: Liver

Metabolites: Norpropylhexedrine, cyclohexylacetoxine, & 4-hydroxypropylhexedrineExcretion: urine